Announcements Trials
Browse Landscape

Status

Enrolling by invitation 1

Sponsor Class

OTHER_GOV 1

Study Type

Observational 1

Sponsor

Cancer Type

Other 1Gastrointestinal 1

Conditions

Stomach Neoplasms 1Pancreatic Neoplasms 1Obesity, Morbid 1Obesity 1Fistula 1Esophageal Neoplasms 1Duodenal Neoplasms 1Colonic Neoplasms 1Bile Duct Neoplasms 1Anastomotic Leak 1

Interventions

Oxaliplatin 24Fluorouracil 20Capecitabine 16pembrolizumab 15Nivolumab 15Leucovorin 13Trastuzumab 9fludarabine 8Paclitaxel 8Drug Therapy 8Docetaxel 8Cyclophosphamide 8S 1 (combination) 7trastuzumab deruxtecan 6Specimen Handling 6Cisplatin 6Magnetic Resonance Spectroscopy 5Bevacizumab 5zolbetuximab 4Irinotecan 4Biopsy 4zimberelimab 3sintilimab 3fludarabine phosphate 3atezolizumab 3aldesleukin 3XELOX 3Surgical Procedures, Operative 3Ramucirumab 3Radiotherapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Stomach Neoplasms × Stents × 90 days × Clear all
NCT06862479 2026-05-06

ES-LCCE-UDFM

Unidade Local de Saúde Santa Maria

Enrolling by invitation
180 enrolled
GastrointestinalOther

Esophageal Neoplasms, Fistula, Obesity, Obesity, Morbid, Stomach Neoplasms, Anastomotic Leak

Data powered by HemOnc (CC BY 4.0) Colophon âš¡